117 related articles for article (PubMed ID: 7828652)
1. Inhibition of L-type Ca2+ channels in portal vein myocytes by the enantiomers of oxodipine.
Baron A; Rakotoarisoa L; Leprêtre N; Mironneau J
Eur J Pharmacol; 1994 Sep; 269(1):105-13. PubMed ID: 7828652
[TBL] [Abstract][Full Text] [Related]
2. Electrophysiological and radioligand binding studies of elgodipine and derivatives in portal vein myocytes.
Lepretre N; Arnaudeau S; Mironneau J; Rakotoarisoa L; Mironneau C; Galiano A
J Pharmacol Exp Ther; 1994 Dec; 271(3):1209-15. PubMed ID: 7996428
[TBL] [Abstract][Full Text] [Related]
3. Effect of dihydropyridines on calcium channels in isolated smooth muscle cells from rat vena cava.
Mironneau J; Yamamoto T; Sayet I; Arnaudeau S; Rakotoarisoa L; Mironneau C
Br J Pharmacol; 1992 Feb; 105(2):321-8. PubMed ID: 1373097
[TBL] [Abstract][Full Text] [Related]
4. Ca2+ channel inhibition by a new dihydropyridine derivative, S11568, and its enantiomers S12967 and S12968.
Randle JC; Lombet A; Nagel N; Abraham C; Aptel H; Peglion JL; Renaud JF
Eur J Pharmacol; 1990 Nov; 190(1-2):85-96. PubMed ID: 1706275
[TBL] [Abstract][Full Text] [Related]
5. Effects of oxodipine and elgodipine on (+)-[3H]-isradipine binding to cardiac and vascular membranes: cardiovascular selectivity.
Rakotoarisoa L; Leprêtre N; Mironneau J; Galiano A; Mironneau C
Fundam Clin Pharmacol; 1994; 8(6):546-52. PubMed ID: 7721232
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of Ca2+ channel blockade by oxodipine and elgodipine in rat cardiomyocytes.
Galán L; Talavera K; Vassort G; Alvarez JL
Eur J Pharmacol; 1998 Sep; 357(1):93-105. PubMed ID: 9788778
[TBL] [Abstract][Full Text] [Related]
7. (+)-[3H]-PN 200-110 binding to cell membranes and intact strips of portal vein smooth muscle: characterization and modulation by membrane potential and divalent cations.
Dacquet C; Loirand G; Rakotoarisoa L; Mironneau C; Mironneau J
Br J Pharmacol; 1989 May; 97(1):256-62. PubMed ID: 2524235
[TBL] [Abstract][Full Text] [Related]
8. Depolarization-evoked increases in cytosolic calcium concentration in isolated smooth muscle cells of rat portal vein.
Kamishima T; McCarron JG
J Physiol; 1996 Apr; 492 ( Pt 1)(Pt 1):61-74. PubMed ID: 8730583
[TBL] [Abstract][Full Text] [Related]
9. Radioligand and functional estimates of the interaction of the 1,4-dihydropyridines, isradipine and lacidipine, with calcium channels in smooth muscle.
Salomone S; Godfraind T
Br J Pharmacol; 1993 May; 109(1):100-6. PubMed ID: 8495233
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a direct interaction of thapsigargin with voltage-dependent Ca2+ channel.
Buryi V; Morel N; Salomone S; Kerger S; Godfraind T
Naunyn Schmiedebergs Arch Pharmacol; 1995 Jan; 351(1):40-5. PubMed ID: 7715740
[TBL] [Abstract][Full Text] [Related]
11. Studies on Ca channels in intact cardiac cells: voltage-dependent effects and cooperative interactions of dihydropyridine enantiomers.
Kokubun S; Prod'hom B; Becker C; Porzig H; Reuter H
Mol Pharmacol; 1986 Dec; 30(6):571-84. PubMed ID: 2431263
[TBL] [Abstract][Full Text] [Related]
12. Effects of oxodipine on 45Ca movements and contractile responses in vascular smooth muscle.
Tamargo J; Tejerina T
Br J Pharmacol; 1989 Jun; 97(2):339-46. PubMed ID: 2758219
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology of Ca2+ channels in smooth muscle.
Mironneau J
Z Kardiol; 1991; 80 Suppl 7():43-6. PubMed ID: 1665262
[TBL] [Abstract][Full Text] [Related]
14. (+)-isradipine but not (-)-Bay-K-8644 exhibits voltage-dependent effects on cat adrenal catecholamine release.
López MG; Michelena P; Gandía L; García AG
Br J Pharmacol; 1991 Feb; 102(2):289-96. PubMed ID: 1707711
[TBL] [Abstract][Full Text] [Related]
15. Modulation of electrical activity and of intracellular calcium oscillations of smooth muscle cells by calcium antagonists, agonists, and vasopressin.
Knot HJ; de Ree MM; Gähwiler BH; Rüegg UT
J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S7-14. PubMed ID: 1725008
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II-activated Ca2+ entry-induced release of Ca2+ from intracellular stores in rat portal vein myocytes.
Morel JL; Macrez-Leprêtre N; Mironneau J
Br J Pharmacol; 1996 May; 118(1):73-8. PubMed ID: 8733578
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic and radioligand binding studies of 1,4-dihydropyridines in rat cardiac and vascular preparations: stereoselectivity and voltage dependence of antagonist and activator interactions.
Zheng W; Stoltefuss J; Goldmann S; Triggle DJ
Mol Pharmacol; 1992 Mar; 41(3):535-41. PubMed ID: 1372088
[TBL] [Abstract][Full Text] [Related]
18. Voltage-dependent binding of 1,4-dihydropyridine Ca2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes.
Wei XY; Rutledge A; Triggle DJ
Mol Pharmacol; 1989 Apr; 35(4):541-52. PubMed ID: 2539561
[TBL] [Abstract][Full Text] [Related]
19. Effects of oxodipine on isolated rabbit aorta and mesenteric resistance vessels.
Tejerina T; Cauvin C; Tamargo J
Eur J Pharmacol; 1992 Aug; 219(2):279-84. PubMed ID: 1425952
[TBL] [Abstract][Full Text] [Related]
20. The actions of azelnidipine, a dihydropyridine-derivative Ca antagonist, on voltage-dependent Ba2+ currents in guinea-pig vascular smooth muscle.
Zhu HL; Tomoda T; Aishima M; Ito Y; Teramoto N
Br J Pharmacol; 2006 Nov; 149(6):786-96. PubMed ID: 17016499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
